Metraipolis › archive › dc_dc655a504c73

Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases — Europe PMC PMID:42827714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42827714
DOI
10.1002/mco2.71029
License (as archived)
solo-consultazione
Archived
2026-10-07T14:29:05.781Z
SHA-256 of the archived text
77030a768315eed4bae17d5da361cd5abad6af8977177517d6d09d6fa00a8959
Stable URL of this page
https://metraipolis.com/documento/dc_dc655a504c73

How to cite

Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases — Europe PMC PMID:42827714 — Europe PMC (en), https://europepmc.org/article/MED/42827714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc655a504c73 (Metraipolis archive dc_dc655a504c73, sha256 77030a768315eed4bae17d5da361cd5abad6af8977177517d6d09d6fa00a8959)
BibTeX
@misc{dcdc655a504c73,
  title = {Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases — Europe PMC PMID:42827714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42827714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc655a504c73; sha256 77030a768315eed4bae17d5da361cd5abad6af8977177517d6d09d6fa00a8959},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42827714. Agents can read the archived copy with the MCP tool read_document.